Antinuclear Antibody Test Market to Reach US$ 3.44 Billion by 2028 in Cumulative Value | Top Players are Trinity Biotech plc, Thermo Fisher Scientific, Antibodies, etc

Increasingly favorable reimbursement policies, rising prevalence of autoimmune disorders, and rapidly increasing geriatric population are some key factors fueling market growth

Market size: USD 1.33 Billion in 2020, Market Growth: CAGR of 12.8%, Market Trends: Increasing initiatives for launching automated laboratories

The Global Antinuclear Antibody Test Market size is expected to reach USD 3.44 billion by 2028 and register a CAGR of 12.8% over the forecast period, according to the latest report by Reports and Data. Increasing investments for research and development activities and rising awareness about autoimmune diseases are some key factors driving global market revenue growth.

Antinuclear Antibodies (ANA) are antibodies that are produced by an individual’s immune system when it is unable to differentiate between self-cells and foreign particles. These are called antinuclear antibodies as they directly target nucleus of the cell. An antinuclear antibody test is used to detect presence of antinuclear antibodies in the blood. Increasing prevalence of autoimmune diseases, Sjogren’s syndrome, rheumatoid arthritis, and systemic lupus erythematosus is a major factor boosting demand for antinuclear antibody test kits. Rising investments and research on developing advanced products, government initiatives, favorable reimbursement policies, and healthcare insurance schemes are key factors further supporting global market revenue growth.

Ask for Sample Report @ https://www.reportsanddata.com/sample-enquiry-form/4080

However, stringent regulatory framework for product approval, high possibility of diagnostic errors, and high costs of equipment are some key factors projected to hamper global market growth going ahead.

Some key highlights from the report:
• Among the product segments, the reagents and assay kits segment is projected to account for significant revenue share between 2021 and 2028. Factors such as increasing prevalence of autoimmune diseases, high demand for assay kits and reagents, and increasing research to develop more advanced testing kits and reagents to understand these autoimmune diseases are factors fueling global market growth.
• Among the technique segments, the immunofluorescence assay segment accounted for largest revenue share in 2020. Rising demand for immunofluorescence assay technique due to its precise analysis and high sensitivity is boosting segment revenue growth and supporting global market growth.
• Among the application segments, the Systemic Lupus Erythematosus (SLE) segment is expected to account for considerably rapid revenue growth rate over the forecast period, driven by increasing government efforts to promote awareness about SLE and increasing availability of FDA-approved tests for diagnosis of SLE.
• Among the end use segments, the hospital segment is expected to account for largest revenue share in the global antinuclear antibody test market. High revenue share is attributable to factors such as rising prevalence of autoimmune diseases and increasing demand for quick diagnosis.
• Asia Pacific market revenue is expected to expand at a CAGR of 12.2% throughout the forecast period. Rising prevalence of autoimmune diseases, increase in healthcare expenditure, and favorable reimbursement schemes offered by governments are some key factors fueling growth of the Asia Pacific antinuclear antibody market.
• North America is projected to account for robust revenue share between 2021 and 2028 due to factors including rising prevalence of autoimmune diseases, adoption of latest technologies, well-developed healthcare infrastructure, and presence of key players in countries in the region.
• Alere Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), ERBA Diagnostics, Inc. (U.S.), Trinity Biotech plc (Ireland), Thermo Fisher Scientific, Inc. (U.S.), Antibodies, Inc. (U.S.), EUROIMMUN AG (Germany), Immuno Concepts (U.S.), Inova Diagnostics (U.S.), and Zeus Scientific, Inc. (U.S.) are some major players operating in the global antinuclear antibody test market.

To know more about the report @ https://www.reportsanddata.com/report-detail/antinuclear-antibody-test-market

For this study, Reports and Data has segmented the global antinuclear antibody test market based on product, technique, application, end use, and region:
Product Outlook (Revenue, USD Billion, 2018-2028)
• Reagents & Assay Kits
• Systems
• Software & Services

Technique Outlook (Revenue, USD Billion, 2018-2028)
• ELISA
• Immunofluorescence Assay
• Multiplex Assay

Application Outlook (Revenue, USD Billion, 2018-2028)
• Rheumatoid Arthritis
• Systemic Lupus Erythematosus
• Sjogren’s Syndrome
• Scleroderma
• Others

End-use Outlook (Revenue, USD Billion, 2018-2028)
• Hospitals
• Clinical Laboratories
• Physician Office Laboratories
• Others

Regional Outlook (Revenue, USD Million, 2018 - 2028)
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Italy
o Rest Of Europe
• Asia Pacific
o China
o India
o Japan
o South Korea
o Rest of APAC
• Latin America
o Brazil
o Rest of LATAM
• Middle East & Africa
o Saudi Arabia
o UAE
o South Africa
o Rest of MEA

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/4080

Benefits of Antinuclear Antibody Test Market Report:
• In-depth understanding of the market size, market share, and market scope of Antinuclear Antibody Test market
• Easy identification of growth opportunities and key product development strategies
• Historical and forecast data for Antinuclear Antibody Test market to ease the decision making process
• Production and consumption ratio, import/export data and company’s market position explained in detailed with graphs and charts to aid in decision making
• Strategic recommendations to established players and new entrants to gain a strong foothold in the market

Request a customization on the report @ https://www.reportsanddata.com/request-customization-form/4080

Thank you for reading our report. For further inquiry or query about customization, kindly get in touch with us to know more. Our team will clear your doubts and ensure the report is customized to meet your requirements.

Browse More Related Reports:
Mammography Market @ http://google.dz/url?q=https://www.reportsanddata.com/report-detail/mammography-market

Laboratory Gas Generators Market @ https://www.google.com.bz/url?q=https://www.reportsanddata.com/report-detail/laboratory-gas-generators-market

Breast Cancer Therapy Market @ https://www.google.kg/url?q=https://www.reportsanddata.com/report-detail/breast-cancer-therapy-market

Clinical Laboratory Services Market @ https://www.google.sc/url?q=https://www.reportsanddata.com/report-detail/clinical-laboratory-services-market

ELISpot and Fluorospot Assay Market @ https://www.google.bf/url?q=https://www.reportsanddata.com/report-detail/elispot-and-fluorospot-assay-market

Contact Us:

John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Reports and Data:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behaviour shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

This release was published on openPR.